Malaysia MDA E-Labelling Guidelines for Home-Use Medical Devices 2026

Malaysia’s Medical Device Authority (MDA) has issued the Seventh Edition of the Guidance Document on Requirements for Labelling of Medical Devices, introducing e-labelling for home-use medical devices. This update provides manufacturers with a modern, flexible approach to delivering instructions and safety information while maintaining regulatory compliance and patient safety.

Key Updates in the 2026 Labelling Guidelines

The revised guidance focuses on improving accessibility, usability, and safety for home-use devices. Key updates include:

• Implementation of e-labelling as an alternative to traditional printed labels

• Updated readability, legibility, and content requirements

• Guidance on digital accessibility and electronic documentation

• Recommendations for integrating e-labelling with packaging and user manuals

E-labelling aims to reduce reliance on physical labels, allow timely updates, and provide a more user-friendly experience.

Specifics of E-Labelling Content and Presentation

The guidance clarifies the specifics of e-labelling implementation:

• Content requirements: e-labelling must include all information normally required on printed labels, including device identification, intended use, safety instructions, warnings, and regulatory markings.

• Presentation: Electronic instructions can be delivered via a URL, QR code on the device or packaging, or downloadable PDF formats, ensuring easy access for users.

• Printed labels: For certain critical information, printed labels may still be required alongside e-labelling, depending on the device type and risk assessment.

• Risk assessment: Manufacturers must perform a risk assessment to demonstrate that e-labelling does not compromise patient safety, usability, or accessibility. Examples include evaluating readability, electronic device compatibility, and backup access methods.

Impact on Manufacturers and Market Access

The adoption of e-labelling offers several advantages for home-use medical device manufacturers:

• Faster updates to instructions and safety information

• Reduced printing and packaging costs

• Flexibility for multi-language and regional compliance

• Improved accessibility for patients outside clinical settings

Compliance with the e-labelling guidance ensures faster regulatory review and supports safer, more informed device use by end-users.

Compliance Considerations

To meet the new requirements, manufacturers should:

1. Review the Seventh Edition guidance thoroughly.

2. Ensure digital labels meet accessibility, legibility, and completeness standards.

3. Integrate e-labelling with packaging and user documentation where appropriate.

4. Maintain records of all e-labelling versions for regulatory review and inspections.

Non-compliance may affect registration status, market access, or post-market surveillance.

Regulatory Significance

The move toward e-labelling aligns Malaysia with global best practices in medical device regulation, improving efficiency, patient safety, and environmental sustainability. It also reflects growing regulatory flexibility in leveraging digital tools to enhance device information delivery while maintaining compliance.

External Reference

• Official announcement: Malaysia MDA – E-Labelling Guidelines

Internal Reference

• MDA Malaysia Medical Device Registration

‍

‍